Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms

PHASE4CompletedINTERVENTIONAL
Enrollment

1,504

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Nicotine Dependence
Interventions
DRUG

nicotine patch

used according to FDA package label

DRUG

nicotine lozenge

used according to FDA-approved package directions

DRUG

nicotine patch + nicotine lozenge

dosage of both according to FDA-approved dosing schedule

DRUG

bupropion

dosage according to FDA-approved instructions

DRUG

bupropion + lozenge

dosage according to FDA approved standard instructions

DRUG

placebo

dosage same as active drug conditions

Trial Locations (2)

53233

UW-CTRI Milwaukee Research site, Milwaukee

53711

UW-CTRI Madison Research site, Madison

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT00332644 - Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms | Biotech Hunter | Biotech Hunter